Recursion Pharmaceuticals, Inc. (RXRX) — 8-K/A Filings
All 8-K/A filings from Recursion Pharmaceuticals, Inc.. Browse 3 Amended Current Event Report reports with AI-powered summaries and risk analysis.
8-K/A Filings (3)
-
Recursion Pharmaceuticals Files 8-K/A Amendment
— Aug 29, 2025 Risk: low
Recursion Pharmaceuticals, Inc. filed an 8-K/A on August 29, 2025, to amend a previous filing regarding unregistered sales of equity securities. The amendment p -
Recursion Pharma Files 8-K/A Amendment
— Nov 27, 2024 Risk: low
Recursion Pharmaceuticals, Inc. filed an amendment (8-K/A) on November 27, 2024, to its previous report dated November 19, 2024. This amendment pertains to fina -
Recursion Pharma Amends Equity Filing
— Nov 26, 2024 Risk: low
Recursion Pharmaceuticals, Inc. filed an 8-K/A on November 26, 2024, to amend a previous filing regarding unregistered sales of equity securities. The original
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX